| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 10.72 CAD | 0.03 (+0.28%) | 8.78 - 11.30 | -- |
Market data as of 12:00AM 06/18/13. Quotes are delayed by at least 15 min.
This fund's objective is to obtain maximum long-term capital growth. It invests primarily in equity and equity-related securities of companies whose primary operations are outside of North America. The fund may make significant investments in any country including emerging markets and emerging industries of any market.
| Total Return | 1.19% |
|---|---|
| Yield (Trailing 12 Mo.) | 0.52% |
| Expense Ratio | -- |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $500.00 |
| Management Tenure | 15 Years |
| Fund Inception | 06/12/1996 |
| Timeframe | MUTUAL:CIG14110 | S&P 500 | International Equity |
|---|---|---|---|
| 1 Month | 0.84% | 2.34% | 1.18% |
| 3 Month | 3.25% | 8.22% | 3.51% |
| Year-to-Date | 10.53% | 15.37% | 9.79% |
| 1 Year | 23.84% | 27.28% | 27.86% |
| 3 Year | 7.42% | 16.87% | 8.48% |
| 5 Year | 0.18% | 5.43% | -1.83% |
| 10 Year | 3.82% | 7.58% | 4.35% |
| Since Inception | 1.19% | 10.42% | -- |
| Basic Materials | 12.99% | |
|---|---|---|
| Consumer Cyclical | 5.95% | |
| Financial Services | 16.33% | |
| Real Estate | 1.39% | |
| Consumer Defensive | 18.09% | |
| Healthcare | 11.46% | |
| Utilities | 1.51% | |
| Communication Services | 4.83% | |
| Energy | 12.73% | |
| Industrials | 11.35% | |
| Technology | 3.37% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | -- | 10.56 | 10.56 | ||
| Bond | -- | 0.00 | 0.00 | ||
| Other | -- | 0.00 | 0.00 | ||
| Foreign Stock | -- | 85.58 | 85.58 | ||
| Foreign Bond | -- | 0.00 | 0.00 | ||
| Total | -- | 96.14 | 96.14 | ||
| Cash | -- | 3.86 | 3.86 | ||
| Total Net Assets | -- |
|---|---|
| Total Stock Holdings | 61 |
| Total Bond Holdings | 0 |
| Company | YTD Return | % of Assets |
|---|---|---|
| Heineken N.V. | -- | 2.82% |
| Roche Holding AG | 21.67% | 2.82% |
| Novartis AG | 14.18% | 2.70% |
| GlaxoSmithKline PLC | 24.67% | 2.67% |
| WSH | 17.75% | 2.67% |
| Nestle SA | 0.68% | 2.65% |
| COV | 10.96% | 2.61% |
| Vodafone Group PLC ADR | 14.49% | 2.48% |
| Bank of Yokohama | -- | 2.46% |
| Deutsche Boerse AG | 7.82% | 2.34% |
| Valuation | MUTUAL:CIG14110 | Category Range |
|---|---|---|
| Price/Earnings | 12.21 | |
| Price/Book | 1.38 | |
| Price/Sales | 0.86 | |
| Price/Cash Flow | 8.50 | |
| Dividend Yield | 2.52 | |
| LT Earnings | 8.36 | |
| Historical Earnings | 8.6 | |
| Sales Growth | -1.86 | |
| Cash-Flow Growth | -8.02 | |
| Book-Value Growth | 0.78 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Low | |
| Return | Below Avg |
| Pretax Return | 7.42% |
|---|---|
| Tax-adjusted Return | 6.91% |
| Tax Cost Ratio | 0.48% |
| Potential Cap Gains | -- |
